Also found in: Medical, Wikipedia.


pl n
(Biology) biological products such as vaccines and therapeutic sera, used to induce immunity to infectious diseases or harmful substances of biological origin


(ˌbaɪ əˈlɒdʒ ɪks)

n. (used with a pl. v.)
commercial products derived from biotechnology.
References in periodicals archive ?
As previously disclosed in July 2015, Synthetic Biologics was informed by UCLA that magnetic resonance imaging (MRI) analyses were ongoing to evaluate changes in the brain that correlate with improvements seen in clinical outcomes.
Big Market Research added a report "Global Biologics and Biosimilars Industry 2015 Deep Market Research Report, Size, Share, Trends, Growth, Analysis and Forecast" is a professional and depth research report on Global Biologics and Biosimilars industry .
Brand-name biologics can cost between $48,000 and $120,000 a year.
Bristol-Myers Squibb recently held a groundbreaking ceremony at the site of the company's new biologics manufacturing facility in Devens, Massachusetts.
The biologics have had a revolutionary impact on psoriasis treatment, significantly reducing the number of patients who, for years, had been under-treated because of concerns about the side effects of prebiologic therapy.
Euronext, NASDAQ: CRXL) has announced that allied contract manufacturer DSM Biologics has signed a PER.
THOUSAND OAKS - Analysts say Amgen and other biotechnology titans won't necessarily benefit from the government's decision to review biologics and chemically based drugs with the same research unit.
Biologics, an integrated oncology services company, is excited to announce the launch of its new corporate website, Biologicsinc.
Additional worldwide patent filings, co-owned by CSMC and Synthetic Biologics and licensed to the Company, include composition of matter claims that could extend patent protection of SYN-010 to 2035.
It has been widely recognized that today therapeutic biologics (or biopharmaceuticals) have become a new but important type of medication.
Euronext, NASDAQ: CRXL) and allied contract manufacturer DSM Biologics have announced that Crucell has signed a PER.
The FDA is planning to release a draft guidance on follow-on biologics this spring.

Full browser ?